SEP 7, 2026 · JOURNAL ARTICLE
Adjuvant therapy and fear of cancer recurrence in bladder cancer survivors: a cross-sectional pilot study
BMC Urology
A single-centre, underpowered cross-sectional pilot study explicitly designed as hypothesis-generating, with a null primary finding that the authors acknowledge cannot rule out a clinically meaningful effect.
Reported
Sample size79
Median age72 years (IQR 65–77)
Male predominance89.9%